-
Guggenheim Reiterates "Neutral" Rating for Keros Therapeutics (NASDAQ:KROS)
来源: Buzz FX / 18 1月 2025 09:16:17 America/Chicago
Guggenheim Reiterates "Neutral" Rating for Keros Therapeutics (NASDAQ:KROS) Written by MarketBeat January 18, 2025 Share Link copied to clipboard. Keros Therapeutics ( NASDAQ:KROS - Get Free Report ) 's stock had its "neutral" rating reiter
Read more...